Explore the Potential with AI-Driven Innovation
The focused library is created on demand with the latest virtual screening and parameter assessment technology, supported by the Receptor.AI drug discovery platform. This method is more effective than traditional methods and results in higher-quality compounds with better activity, selectivity, and safety.
We pick out particular compounds from an extensive virtual database of more than 60 billion molecules. The preparation and shipment of these compounds are facilitated by our associate Reaxense.
The library includes a list of the most promising modulators annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Also, each compound is presented with its optimal docking poses, affinity scores, and activity scores, providing a comprehensive overview.
Our top-notch dedicated system is used to design specialised libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
The procedure entails thorough molecular simulations of the catalytic and allosteric binding pockets, accompanied by ensemble virtual screening that factors in their conformational flexibility. When developing modulators, the structural modifications brought about by reaction intermediates are factored in to optimize activity and selectivity.
Our library distinguishes itself through several key aspects:
partner
Reaxense
upacc
Q9Y6X5
UPID:
ENPP4_HUMAN
Alternative names:
AP3A hydrolase; Ectonucleotide pyrophosphatase/phosphodiesterase family member 4
Alternative UPACC:
Q9Y6X5; A8K5G1; Q7L2N1
Background:
Bis(5'-adenosyl)-triphosphatase ENPP4, also known as AP3A hydrolase and a member of the ectonucleotide pyrophosphatase/phosphodiesterase family, plays a crucial role in hydrolyzing extracellular Ap3A and Ap4A into AMP, ADP, and ATP. These diadenosine polyphosphates are key in inducing vascular smooth muscle cells proliferation.
Therapeutic significance:
Understanding the role of Bis(5'-adenosyl)-triphosphatase ENPP4 could open doors to potential therapeutic strategies, especially in conditions related to vascular proliferation and thrombosis, by targeting its procoagulant activity and mediation of platelet aggregation.